SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-000357
Filing Date
2021-06-16
Accepted
2021-06-16 08:13:21
Documents
12
Period of Report
2021-06-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K reph-20210614.htm   iXBRL 8-K 44422
  Complete submission text file 0000950170-21-000357.txt   159148

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT reph-20210614.xsd EX-101.SCH 2450
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT reph-20210614_pre.xml EX-101.PRE 9597
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT reph-20210614_lab.xml EX-101.LAB 12936
5 EXTRACTED XBRL INSTANCE DOCUMENT reph-20210614_htm.xml XML 4519
Mailing Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341
Business Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 770-534-8239
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36329 | Film No.: 211020520
SIC: 2834 Pharmaceutical Preparations